Popular Trials
Selective Serotonin Reuptake Inhibitor
Fluoxetine for Anxiety and Depression
Recruiting0 awardsPhase 2
Bethesda, Maryland
This trial uses fMRI to study brain regions engaged in processing motivationally salient stimuli in children, adolescents, and adults with mood and anxiety disorders, in order to better understand how these disorders develop and how they can be treated.
Diagnostic Imaging for Pheochromocytoma
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing better methods to detect, locate, and treat pheochromocytomas. These are tumors that usually form in the adrenal glands and can cause high blood pressure. They can be hard to detect with current methods and can lead to severe medical consequences if left undetected.
Magnetic Resonance Spectroscopy
MRS Brain Imaging for Normal Brain Function
Recruiting1 award
Bethesda, Maryland
This trial will use magnetic resonance spectroscopy to study how the brain metabolizes glucose into specific chemical transmitters. This will help researchers understand how different neurotransmitters are produced.
Popular Filters
Phase 3 Trials
Immunomodulatory Agent
Lenalidomide + Dexamethasone +/- Thalidomide for Multiple Myeloma
Recruiting2 awardsPhase 3
Baltimore, Maryland
This trial tests if lenalidomide with either standard or low-dose dexamethasone works better for new multiple myeloma patients. If not, thalidomide is added. The goal is to find effective treatments with fewer side effects. Lenalidomide plus low-dose dexamethasone has been shown to be an effective treatment for multiple myeloma, particularly in patients who are not candidates for stem cell transplantation.
Trials With No Placebo
Virus Therapy
Virotherapy for Castleman Disease
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is studying a rare disorder caused by the Kaposi's sarcoma herpes virus (KSHV), which also causes several types of cancer. Researchers want to understand the biology of KSHV-associated multicentric Castleman's disease (MCD) to find ways to treat it.
Leptin Analog
Metreleptin for Insulin Resistance
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing whether metreleptin, a medication used to treat patients with leptin deficiency, will improve glycemia control in patients with genetic defects of the insulin receptor. The primary endpoint is hemoglobin A1c and the trial will enroll 20 patients at the NIH Clinical Center.
Tyrosine Kinase Inhibitor
Imatinib or Dasatinib for Chronic Myeloid Leukemia
Recruiting1 awardPhase 2
Newark, Delaware
This trial looks at two different doses of imatinib mesylate and dasatinib to see how well they work in treating patients with previously untreated chronic phase chronic myelogenous leukemia.
Radiation
Low-Dose Radiation + Immunosuppressants for Sickle Cell Disease
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is exploring whether a bone marrow transplant procedure that uses a low dose of radiation and two immunosuppressive drugs is safe for people who are typically excluded from the procedure because of their age.
Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitors for Hypereosinophilic Syndrome
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is for patients with a rare blood disorder called hypereosinophilic syndrome, who have not responded to standard treatment. The study will test whether the drug imatinib mesylate (Gleevec) is safe and effective in reducing blood eosinophils in these patients.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.